Laboratory of Molecular Pharmacology, Division of Pharmaceutical Sciences, Kanazawa University Graduate School, Kanazawa, Ishikawa, Japan.
PLoS One. 2013 May 17;8(5):e63947. doi: 10.1371/journal.pone.0063947. Print 2013.
We have previously shown marked upregulation of the mRNA and corresponding protein for the cellular motor molecule myosin VI (Myo6) after an extremely traumatic stress experience, along with a delayed decrease in 5-bromo-2'-deoxyuridine incorporation in the murine hippocampus, a brain structure believed to undergo adult neurogenesis. In this study, we investigated the role of Myo6 in both proliferation and differentiation in pluripotent P19 cells by using stable transfection and RNA interference techniques.
METHODOLOGY/PRINCIPAL FINDINGS: Stable overexpression of Myo6 not only led to significant inhibition of the reducing activity of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) and the size of clustered aggregates in P19 cells, but also resulted in selectively decreased mRNA expression of the repressor type proneural gene Hes5 without affecting the expression of neuronal and astroglial marker proteins. In P19 cells transfected with Myo6 siRNA, by contrast, a significant increase was found in the size of aggregate and MTT reduction along with increased Sox2 protein levels, in addition to marked depletion of the endogenous Myo6 protein. In C6 glioma cells, however, introduction of Myo6 siRNA induced a drastic decrease in endogenous Myo6 protein levels without significantly affecting MTT reduction. The Ca(2+) ionophore A23187 drastically increased the luciferase activity in P19 cells transfected with a Myo6 promoter reporter plasmid, but not in HEK293, Neuro2A and C6 glioma cells transfected with the same reporter.
CONCLUSIONS/SIGNIFICANCE: These results suggest that Myo6 may play a predominant pivotal role in the mechanism underlying proliferation without affecting differentiation to progeny lineages in pluripotent P19 cells.
我们之前已经表明,在经历了极其创伤的应激体验后,细胞运动分子肌球蛋白 VI(Myo6)的 mRNA 和相应蛋白的表达明显上调,同时在我们认为会发生成年神经发生的大脑结构——小鼠海马体中,5-溴-2'-脱氧尿苷的掺入减少。在这项研究中,我们通过稳定转染和 RNA 干扰技术研究了 Myo6 在多能 P19 细胞中的增殖和分化中的作用。
方法/主要发现:Myo6 的稳定过表达不仅导致 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基-2H-四唑溴盐(MTT)的还原活性和 P19 细胞中聚集物的大小显著降低,而且还导致抑制型神经前基因 Hes5 的 mRNA 表达选择性降低,而不影响神经元和神经胶质标志物蛋白的表达。相比之下,在转染了 Myo6 siRNA 的 P19 细胞中,聚集物的大小和 MTT 还原显著增加,同时 Sox2 蛋白水平升高,以及内源性 Myo6 蛋白的明显耗竭。然而,在 C6 神经胶质瘤细胞中,引入 Myo6 siRNA 会导致内源性 Myo6 蛋白水平急剧下降,而不会显著影响 MTT 还原。钙离子载体 A23187 可显著增加转染 Myo6 启动子报告质粒的 P19 细胞中的荧光素酶活性,但对转染相同报告质粒的 HEK293、Neuro2A 和 C6 神经胶质瘤细胞没有影响。
结论/意义:这些结果表明,Myo6 可能在多能 P19 细胞的增殖机制中发挥主要关键作用,而不影响向祖细胞谱系的分化。